Skip to main content
. 2023 Feb 2;15(2):e34572. doi: 10.7759/cureus.34572

Figure 2. Pharmacological management of hypertension in CKD patients.

Figure 2

1: [50], 2: [51], 3: [52], 4: [53], 5: [54], 6: [55], 7: [56], and 8: [57]

RAAS, renin-angiotensin-aldosterone system; ACE, angiotensin-converting enzyme; ARBs, angiotensin receptor blockers; CKD, chronic kidney disease; BP, blood pressure; KDIGO, Kidney Disease: Improving Global Outcomes; GFR, glomerular filtration rate; HT, hypertension; T2DM, type 2 diabetes mellitus